Oncocytoma, renal
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although the origin of RO remains unclear, our findings suggest that FOXI1 immunohistochemistry is useful in differential diagnosis of RO from chRCC with overlapping histology.
|
31177114 |
2019 |
Congenital diverticulum of pharynx
|
0.010 |
Biomarker
|
disease |
BEFREE |
Foxi1 promotes late-stage pharyngeal pouch morphogenesis through ectodermal Wnt4a activation.
|
29932895 |
2018 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, to the best of our knowledge, our findings are the first to demonstrate that Foxi1 is a key player in the transcriptional control of miR-491-5p and that miR-491-5p acts as an anti-oncogene by targeting Wnt3a/β-catenin signaling in GC.
|
28358374 |
2017 |
Chromophobe Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although the origin of RO remains unclear, our findings suggest that FOXI1 immunohistochemistry is useful in differential diagnosis of RO from chRCC with overlapping histology.
|
31177114 |
2019 |
Distal Renal Tubular Acidosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in adenosine triphosphate ATP6V1 (B1 H<sup>+</sup>-ATPase subunit), ATPV0A4 (a4 H<sup>+</sup>-ATPase subunit), SLC4A1 (anion exchanger 1), and FOXI1 (forkhead transcription factor) cause distal renal tubular acidosis type I. Carbonic anhydrase II mutations affect several nephron segments and give rise to a mixed proximal and distal phenotype.
|
31300090 |
2019 |
DEAFNESS, AUTOSOMAL RECESSIVE (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
The FOXI1 gene, which causes autosomal recessive deafness (OMIM 600791, DFNB4) when mutated, was contained within the uniparental isodisomy region (5q34-qter).
|
23824987 |
2013 |
Unilateral deafness
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, these data suggest that SLC26A4, FOXI1 and KCNJ10 are not major determinants in unilateral deafness and enlarged vestibular aqueduct compared with their implication in Pendred syndrome and non-syndromic bilateral enlarged vestibular aqueduct.
|
20621367 |
2010 |
Enlarged Vestibular Aqueduct
|
0.400 |
Biomarker
|
phenotype |
CLINGEN |
Expression of marker genes during early ear development in medaka.
|
16950663 |
2007 |
Enlarged Vestibular Aqueduct
|
0.400 |
Biomarker
|
phenotype |
CLINGEN |
Lack of pendrin expression leads to deafness and expansion of the endolymphatic compartment in inner ears of Foxi1 null mutant mice.
|
12642503 |
2003 |
Enlarged Vestibular Aqueduct
|
0.400 |
Biomarker
|
phenotype |
CLINGEN |
This finding is consistent with our observation that EVA occurs in the Slc26a4(+/-); Foxi1(+/-) double-heterozygous mouse mutant.
|
17503324 |
2007 |
Enlarged Vestibular Aqueduct
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Enlarged Vestibular Aqueduct
|
0.400 |
Biomarker
|
phenotype |
CLINGEN |
Using next-generation sequencing technology, we set up a multiple polymerase chain reaction enrichment system for target regions of EVA pathogenic genes (SLC26A4, FOXI1, and KCNJ10).
|
27997596 |
2016 |
Enlarged Vestibular Aqueduct
|
0.400 |
Biomarker
|
phenotype |
CLINGEN |
Zebrafish foxi one modulates cellular responses to Fgf signaling required for the integrity of ear and jaw patterning.
|
12702667 |
2003 |
Enlarged Vestibular Aqueduct
|
0.400 |
Biomarker
|
phenotype |
CLINGEN |
The winged helix transcription factor Fkh10 is required for normal development of the inner ear.
|
9843211 |
1998 |
Renal tubular acidosis
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Acidosis and Deafness in Patients with Recessive Mutations in FOXI1.
|
29242249 |
2018 |
Deafness
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Acidosis and Deafness in Patients with Recessive Mutations in FOXI1.
|
29242249 |
2018 |
hearing impairment
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Acidosis and Deafness in Patients with Recessive Mutations in FOXI1.
|
29242249 |
2018 |
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Goiter
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Respiratory Insufficiency
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Vertigo
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Vestibular dysfunction
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cochlear malformation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypoplasia of the cochlea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of metabolism/homeostasis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|